Intelligence
Decision intelligence for clinical trial design
Protocol design validation powered by historical precedent. Plus therapeutic area dashboards and competitive landscape analysis.
New22,704 trials analyzed
Protocol Risk Scan
Validate your Phase 2 oncology protocol design against historical precedent. Endpoint analysis, enrollment feasibility benchmarks, and indication-specific patterns — all sourced to specific trials.
Learn moreTherapeutic dashboards
LiveUpdated monthly
GLP-1 trial landscape intelligence
Pipeline analysis, trial design patterns, and competitive positioning across the GLP-1/GIP therapeutic area. Data from ClinicalTrials.gov, openFDA, and PubMed.
View dashboardLive1,451+ devices
FDA AI medical device tracker
Every FDA-authorized AI medical device analyzed by specialty, regulatory pathway, validation evidence, and clinical trial relevance. The practitioner layer the raw FDA list doesn't give you.
View tracker